<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03524885</url>
  </required_header>
  <id_info>
    <org_study_id>H1506438508468</org_study_id>
    <nct_id>NCT03524885</nct_id>
  </id_info>
  <brief_title>Standard Implants With Bone Regeneration vs Short Implants</brief_title>
  <official_title>Standard Implants With Bone Regeneration vs Short Implants (Implantes Convencionales Con regeneración ósea vs. Implantes Cortos)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Valencia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Valencia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study designed as a randomized controlled trial of parallel group design will be conducted&#xD;
      at the Dental clinic of the University of Valencia to compare, considering different&#xD;
      parameters, the rehabilitation with dental implants of atrophic posterior mandibles or&#xD;
      maxillae using short implants or longer implants with vertical bone regeneration with GBR.&#xD;
&#xD;
      The hypothesis of the study is that both treatment options will be successful to rehabilitate&#xD;
      atrophic posterior mandibles or maxillae. Moreover, more surgical complications will be&#xD;
      encountered in the bone regeneration group.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peri-implant bone level changes</measure>
    <time_frame>12 months after implant loading</time_frame>
    <description>Interproximal bone level measured on a periapical film taken with a Rinn Holder</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>12 months after implant loading</time_frame>
    <description>by means a Visual Analogue Scale ranging between 0 (lowest) and 10 (highest)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant survival rate</measure>
    <time_frame>12 months after implant loading</time_frame>
    <description>% of implants in function</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Implant Complication</condition>
  <condition>Bone Resorption</condition>
  <arm_group>
    <arm_group_label>Short implants</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 or 3 implant 4-5 mm length and 4 mm diameter (Syra Short, Sweden &amp; Martina, Padua, Italy) will be positioned. The healing cap will be immediately connected and a vycril suture will be done after soft tissue reflection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bone regeneration with longer implants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A horizontal and vertical regeneration following GBR technique will be performed using not-resorbable PTFE titanium reinforced membrane (Cytoplast Osteogenics, US) fixed by titanium pins or miniscrews to ensure the perfect stability (Pro-fix, Cytoplast Osteogenics, US).&#xD;
The graft will be composed half autogenous bone harvested with a scraper (Meta, Firenze, Italy) by the same surgical site or by a second tunnel site in the mandibular ramus and half deproteinized bovine bone (Bio Oss Geislicht Pharma, Switzerland). The mucosal flaps will be sutured in a double layer with horizontal mattress and single gore-tex sutures (Cytoplast PTFE sutures 3.0, Cytoplast Osteogenics, US).&#xD;
2 or 3 implant from 10 to 13 mm length putting the implant platform 2 or 3 mm apical to CEJ of the adjacent tooth will be inserted.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Short implant placement</intervention_name>
    <description>Ten patients will be randomly selected for the short implants option, 2 or 3 implant 4-5 mm length and 4 mm diameter (Syra Short, Sweden &amp; Martina, Padua, Italy) will be positioned. The healing cap will be immediately connected and a vycril suture will be done after soft tissue reflection.&#xD;
After three months an acrylic screw-retained bridge will be delivered. After further three months, a definitive restauration with a metal ceramic bridge will be seated.</description>
    <arm_group_label>Short implants</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bone regeneration with longer implants</intervention_name>
    <description>Ten patients will be randomly assigned to the regenerative group, 2 or 3 implant from 10 to 13 mm length intentionally exposed putting the implant platform 2 or 3 mm apical to CEJ of the adjacent tooth will be inserted.&#xD;
A horizontal and vertical regeneration following GBR technique will be performed using not-resorbable PTFE titanium reinforced membrane (Cytoplast Osteogenics, US) fixed by titanium pins or miniscrews to ensure the perfect stability (Pro-fix, Cytoplast Osteogenics, US).</description>
    <arm_group_label>Bone regeneration with longer implants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All the patients with a distal edentulism Kennedy -Applegate Class II in the posterior&#xD;
             mandible or maxilla, with residual bone height from the top of the crest to the&#xD;
             opposite landmark (the alveolar nerve for the lower and the sinus cavity for the&#xD;
             upper) between 5 and 7 millimeters. The bone peak on the last tooth before the&#xD;
             edentulous space must be positioned from 2 to 4 mm from the CEJ. (X-ray evaluation by&#xD;
             periapical film on a Rinn Holder).&#xD;
&#xD;
          -  All patients with at least 3 mm of keratinized tissue on the edentulous crest. In case&#xD;
             of absence of this prerequisite, three months before the keratinized tissue is&#xD;
             augmented by a ephytelium-connective tissue graft harvested from the palate.&#xD;
&#xD;
          -  Patients with edentulous distal sites&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Heavy smokers (more than 10 cigarettes /day)&#xD;
&#xD;
          -  Patients with active periodontal disease: full mouth plaque index (FMPI &gt; 20%) and&#xD;
             Full mouth bleeding index (FMBI &gt; 20%).&#xD;
&#xD;
          -  Patients with less of 5 mm of bone width.&#xD;
&#xD;
          -  Patients with systemic conditions or under prescription of medications that&#xD;
             contraindicate oral surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>David Peñarrocha Oltra</last_name>
    <phone>649952560</phone>
    <email>david.penarrocha@uv.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clínica Odontológica de la Universitat de Valencia, Fundación Lluis Alcanyis</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Peñarrocha Oltra</last_name>
      <phone>649952560</phone>
      <email>david.penarrocha@uv.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>March 3, 2018</study_first_submitted>
  <study_first_submitted_qc>May 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2018</study_first_posted>
  <last_update_submitted>November 11, 2018</last_update_submitted>
  <last_update_submitted_qc>November 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Valencia</investigator_affiliation>
    <investigator_full_name>David Peñarrocha Oltra</investigator_full_name>
    <investigator_title>Assistanat Postdoctoral Lecturer (Profesor Ayudante Doctor)</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Resorption</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

